TERTp mutations, as a late event in tumor progression (55, 98), can also occur simultaneously with BRAF or RAS mutations in poorly differentiated and anaplastic thyroid cancers (99, 100), enhancing tumor aggressiveness (100–105). Here, BRAF is linked to thyroid gland undifferentiated (anaplastic) carcinoma.